Webinar: NMOSD – Clinical Insights and Recent Advances
Join the webinar on advances in immunotherapy for NMOSD, MOGAD, and autoimmune encephalitis.
Discover new data from ECTRIMS 2025, immunopathological insights, and future treatment perspectives.
Invitation: NMOSD Webinar – Clinical Insights and Recent Advances
Date: Tuesday, October 14, 2025
Time: 16:00–17:00 (CEST)
Topic: Advances in Immunotherapy for NMOSD, MOGAD, and Autoimmune Encephalitis
Registration deadline: October 12, 2025
PROGRAM
Chair: Zsolt Illes, Odense University Hospital, Denmark
NMOSD: News from ECTRIMS 2025
Zsolt Illes, Odense University Hospital, Denmark
The immunopathological hallmarks of neuromyelitis optica spectrum disorder (NMOSD)
Nikolaos Grigoriadis, Aristotle University of Thessaloniki, Greece
The future of immunotherapies in NMOSD, MOGAD, and autoimmune encephalitis
Paul Friedemann, Charité-Universitätsmedizin Berlin, Germany
Immunotherapies in NMOSD, and MOGAD
Paulus Rommer, Medical University of Vienna, Austria
Presentation title TBD
Viktoria Papp, Odense University Hospital, Denmark
The program is subject to change.
The webinar is free for doctors and nurses working within the relevant field.
Representatives from the pharmaceutical industry are kindly asked to contact Charlotte Knudtzen at ckn@bpno.dk or Ina Bøgkjær at ibo@bpno.dk for further information regarding participation.
Sign up
